OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
7.31
+0.37 (5.33%)
Nov 18, 2026, 4:00 PM EST - Market closed
OptimizeRx Revenue
OptimizeRx had revenue of $21.62M in the quarter ending September 30, 2026, a decrease of -17.08%. This brings the company's total for the last twelve months to $94.20M, down -13.98% year-over-year. In the year 2025, OptimizeRx had annual revenue of $109.43M with 18.78% growth. That makes OptimizeRx the 23,177th largest company in the world by revenue and 3,329th in the United States.
Revenue (ttm)
$94.20M
Revenue Growth
-13.98%
P/S Ratio
1.47
Revenue / Employee
$708,286
Employees
133
Market Cap
138.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.43M | 17.30M | 18.78% |
| Dec 31, 2024 | 92.13M | 20.61M | 28.81% |
| Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
| Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
| Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
| Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
| Dec 31, 2019 | 24.60M | 3.39M | 15.99% |
| Dec 31, 2018 | 21.21M | 9.08M | 74.86% |
| Dec 31, 2017 | 12.13M | -3.38M | -21.77% |
| Dec 31, 2016 | 15.50M | 8.28M | 114.70% |
| Dec 31, 2015 | 7.22M | 717.72K | 11.04% |
| Dec 31, 2014 | 6.50M | 1.82M | 38.96% |
| Dec 31, 2013 | 4.68M | 2.69M | 135.27% |
| Dec 31, 2012 | 1.99M | -233.95K | -10.52% |
| Dec 31, 2011 | 2.22M | 2.08M | 1,464.09% |
| Dec 31, 2010 | 142.13K | 115.41K | 431.86% |
| Dec 31, 2009 | 26.72K | -56.96K | -68.07% |
| Dec 31, 2008 | 83.69K | -16.63K | -16.58% |
| Dec 31, 2007 | 100.32K | - | - |
| Dec 31, 2006 | 0 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 2.34B |
| Claritev | 1.02B |
| Health Catalyst | 272.21M |
| So-Young International | 240.51M |
| Definitive Healthcare | 227.31M |
| American Well | 211.23M |
| LifeMD | 189.24M |
| NRC Health | 143.79M |
OPRX News
- 2 days ago - OptimizeRx to Participate in the 15th Annual ROTH Technology Conference - GlobeNewsWire
- 6 days ago - OptimizeRx price target lowered to $10.50 from $11 at B. Riley - TheFly
- 6 days ago - OptimizeRx price target lowered to $10 from $11 at Lake Street - TheFly
- 6 days ago - OptimizeRx price target lowered to $11 from $12 at Stifel - TheFly
- 7 days ago - OptimizeRx Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - OptimizeRx Earnings release: Q3 2026 - Filings
- 7 days ago - OptimizeRx Quarterly report: Q3 2026 - Filings
- 7 days ago - OptimizeRx reports Q3 EPS 20c, consensus 16c - TheFly